Summary
Background
Psoriasis is associated with cardiovascular disease, inflammatory bowel disease (IBD), metabolic syndrome, and psychiatric disease. Furthermore, psoriasis is associated with immune dysregulation and systemic inflammation.
Objective
To determine the association of psoriasis and psoriatic arthritis with IBD and the association of the combination of psoriasis or psoriatic arthritis with IBD and other gastrointestinal illnesses.
Methods
Discharge data from the 2000–2014 Nationwide Inpatient Sample, Healthcare Cost and Utilization Project (HCUP), which approximates a 20% stratified sample of all US hospitalizations, were analyzed. Multivariable logistic regression was used to examine the association between psoriasis and psoriatic arthritis with IBD and 23 gastrointestinal illnesses adjusting for sociodemographic characteristics.
Results
Psoriasis was associated with IBD (Crohn’s disease adjusted odds ratio (aOR) = 2.13, 95% confidence interval (CI) [2.0–2.3], p < 0.001). When adjusting for sociodemographics and IBD, psoriasis was associated with 21 of 23 gastrointestinal diseases examined, most notably celiac disease, autoimmune hepatitis, and non-alcoholic fatty liver disease. Psoriatic arthritis was also associated with IBD (Crohn’s disease, aOR = 1.95, 95% CI [1.7–2.2], and ulcerative colitis, aOR = 2.66, 95% CI [2.4–2.9]).
Conclusion
Psoriasis and psoriatic arthritis inpatients have an associated increase in IBD and numerous other gastrointestinal illnesses.
Similar content being viewed by others
References
Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T, (eds.). Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. Journal of Investigative Dermatology Symposium Proceedings; 2004 Mar;9(2):136–9. https://doi.org/10.1046/j.1087-0024.2003.09102.x.
Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141(12):1537–41.
Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol. 2009;60(2):218–24.
Smith A, Kassab J, Payne R, Beer W. Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology. 1993;186(3):181–6.
Farber EM, Nall L, Strefling A. Psoriasis: a disease of the total skin. J Am Acad Dermatol. 1985;12(1):150–6.
Friedman S, Rubin PH, Bodian C, Goldstein E, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic Crohn’s colitis. Gastroenterology. 2001;120(4):820–6.
Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn’s disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology. 1998;114(6):1161–8.
Loftus E, Silverstein M, Sandborn W, Tremaine W, Harmsen W, Zinsmeister A. Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gut. 2000;46(3):336–43.
Skroza N, Proietti I, Pampena R, La Viola G, Bernardini N, Nicolucci F, et al. Correlations between psoriasis and inflammatory bowel diseases. Biomed Res Int. 2013; https://doi.org/10.1155/2013/983902.
Sánchez FO, Reddy MPL, Sakuraba K, Ståhle M, Alarcón-Riquelme ME. IFN-regulatory factor 5 gene variants interact with the class I MHC locus in the Swedish psoriasis population. J Investig Dermatol. 2008;128(7):1704–9.
Eppinga H, Sperna Weiland CJ, Thio HB, van der Woude CJ, Nijsten TE, Peppelenbosch MP, et al. Similar depletion of protective faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in hHidradenitis sSuppurativa. J Crohns Colitis. 2016;10(9):1067–75. https://doi.org/10.1093/ecco-jcc/jjw070.
Cottone M, Sapienza C, Macaluso FS, Cannizzaro M. Psoriasis and inflammatory bowel disease. Dig Dis. 2019;37(6):451–7. https://doi.org/10.1159/000500116.
Vavricka SR, Brun L, Ballabeni P, Pittet V, Vavricka BMP, Zeitz J, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106(1):110–9.
Cohen A, Dreiher J, Birkenfeld S. Psoriasis associated with ulcerative colitis and Crohn’s disease. J Eur Acad Dermatol Venereol. 2009;23(5):561–5. https://doi.org/10.1111/j.1468-3083.2008.03031.x.
Makredes M, Robinson D Jr, Bala M, Kimball AB. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J Am Acad Dermatol. 2009;61(3):405–10.
Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology. 2005;129(3):827–36.
Persson PG, Leijonmarck CE, Bernell O, Hellers G, Ahlbom A. Risk indicators for inflammatory bowel disease. Int J Epidemiol. 1993;22(2):268–72.
Agency for Healthcare Research and Quality. HCUP databases. Healthcare cost and utilization project (HCUP). 2019. www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 1 March 2020.
Whalen D, Houchens R, Elixhauser A. 2002 HCUP nationwide inpatient sample (NIS) comparison report. HCUP method series report# 2007-03. Rockville: US Agency for Healthcare Research and Quality; 2007.
Icen M, Crowson CS, McEvoy MT, Gabriel SE, Maradit Kremers H. Potential misclassification of patients with psoriasis in electronic databases. J Am Acad Dermatol. 2008;59(6):981–5. https://doi.org/10.1016/j.jaad.2008.08.034.
Asgari MM, Wu JJ, Gelfand JM, Salman C, Curtis JR, Harrold LR, et al. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009. Pharmacoepidemiol Drug Saf. 2013;22(8):842–9. https://doi.org/10.1002/pds.3447.
Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143(5):1179–1187.e3. https://doi.org/10.1053/j.gastro.2012.08.002.
Fu Y, Lee CH, Chi CC. Association of psoriasis with inflammatory bowel disease: a systematic review and meta-analysis. JAMA Dermatol. 2018;154(12):1417–23. https://doi.org/10.1001/jamadermatol.2018.3631.
Ren Z, Hsu DY, Brieva J, Silverberg NB, Langan SM, Silverberg JI. Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A. Br J Dermatol. 2017;176(1):87–99. https://doi.org/10.1111/bjd.14821.
Hsu D, Brieva J, Silverberg JI. Costs of care for hospitalization for pemphigus in the United States. JAMA Dermatol. 2016;152(6):645–54. https://doi.org/10.1001/jamadermatol.2015.5240.
Hsu DY, Gordon K, Silverberg JI. Serious infections in hospitalized patients with psoriasis in the United States. J Am Acad Dermatol. 2016;75(2):287–96. https://doi.org/10.1016/j.jaad.2016.04.005.
Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH. Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw. 2012;49(5):1–15.
Poikolainen K, Reunala T, Karvonen J. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol. 1994;130(4):473–7.
Poikolainen K, Reunala T, Karvonen J, Lauharanta J, Kärkkäinen P. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ. 1990;300(6727):780–3.
Chen Y‑J, Wu C‑Y, Chen T‑J, Shen J‑L, Chu S‑Y, Wang C‑B, et al. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan. J Am Acad Dermatol. 2011;65(1):84–91.
Boffetta P, Gridley G, Lindelöf B. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Investig Dermatol. 2001;117(6):1531–7.
Miele L, Vallone S, Cefalo C, La Torre G, Di Stasi C, Vecchio FM, et al. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009;51(4):778–86.
Frentz G, Olsen J. Malignant tumours and psoriasis: a follow-up study. Br J Dermatol. 1999;140(2):237–42.
Hannuksela-Svahn A, Pukkala E, Läärä E, Poikolainen K, Karvonen J. Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Investig Dermatol. 2000;114(3):587–90.
Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Investig Dermatol. 1988;91(3):197–201. https://doi.org/10.1111/1523-1747.ep12464847.
Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex. World J Gastroenterol. 2006;12(23):3628.
Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L, et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet. 2007;122(2):201–6.
Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 2012;181(1):8–18. https://doi.org/10.1016/j.ajpath.2012.03.044.
Chiricozzi A, Krueger JG. IL-17 targeted therapies for psoriasis. Expert Opin Investig Drugs. 2013;22(8):993–1005.
Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003;52(1):65–70.
Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015;67(1):128–39.
Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009;60(3):394–401. https://doi.org/10.1016/j.jaad.2008.10.062.
Kappelman MD, Moore KR, Allen JK, Cook SF. Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci. 2013;58(2):519–25.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
A. Yousaf, R. Raiker, S.M. Davis, S. Gayam and Z. Zinn declare that they have no competing interests.
Ethical standards
Ethics approval: approved by the West Virginia University institutional review board, protocol # 2002899647.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Caption Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Yousaf, A., Raiker, R., Davis, S.M. et al. Association between psoriasis, psoriatic arthritis and gastrointestinal disease. Wien Klin Wochenschr 133, 586–593 (2021). https://doi.org/10.1007/s00508-020-01740-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-020-01740-8